CD4+ β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice

Journal of Experimental Medicine

Volumn 182, Issue 1, 1995, Pages 87-97

  Akhtar, Irfan ^a   Gold, Jennifer P ^a   Pan, Lu Ying ^a   Ferrara, James L M ^a,b   Yang, Xiao Dong ^c,d   Kim, James I ^a   Tan, Kut Nie ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; FEMALE; HELPER CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE CLONE; LYMPHOCYTIC INFILTRATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PREVENTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMAL; AUTOANTIGENS; AUTOIMMUNE DISEASES; BASE SEQUENCE; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RADIATION CHIMERA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TH1 CELLS; TH2 CELLS;

EID: 0029053581     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.1.87     Document Type: Article

References (54)

1. Castano, L., and G.S. Eisenbarth. 1990. Type I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8: 647-679.
2. Haskins, K., and M. McDuffie. 1990. Acceleration of diabetes in young NOD mice by CD4+ islet specific T cell clone. Science (Wash. DC). 249: 1433-1436.
3. Nakano, N., H. Kikutani, H. Nishimoto, and T. Kishimoto. 1991. T cell receptor V gene usage of islet β cell-reactive T cells is not restricted in non-obese diabetic mice. J. Exp Med. 173: 1091-1097.
4. Reich, E.-P., R.S. Sherwin, O. Kanagawa, and C.A. Janeway. 1989. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature (Lond.). 341: 326-329.
5. Tisch, R., X.-D. Yang, S.M. Singer, R.S. Libau, L. Fugger, and H.O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (Lond.). 366: 72-75.
6. Kaufman, D.L., M. Calre-Salzler, J. Tian, T. Forsthuber, G.S.P. Ting, P. Robinson, M.A. Atkinson, E.E. Sercarz, A.J. Tobin, and P.V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in mature insulin-dependent diabetes. Nature (Lond.). 366: 69-72.
7. Todd, J.A. 1990. Genetic control of autoimmunity in type 1 diabetes. Immunol. Today. 11: 122-129.
8. Nishimoto, H., H. Kikutani, K.-I. Yamamura, and T. Kishimoto. 1987. Prevention of autoimmune insulitus by expression of I-E molecules in NOD mice. Nature (Lond.). 328: 432-434.
9. Bohme, J., B. Schuhbaur, O. Kanagawa, C. Benoist, and D. Mathis. 1990. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science (Wash. DC). 249: 293-295.
10. NOD to the development of insulitis in non-obese diabetic mice. Nature (Lond.). 345: 722-724.
11. K transgenic mice. Nature (Lond.). 345: 724-726.
12. Lund, T., L. O’Reily, P. Hutchings, O. Kanagawa, E. Simpson, R. Gravely, P. Chandler, J. Dyson, J.K. Picard, A. Edwards, et al. 1990. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature (Lond.). 345: 727-729.
13. Katz, J.D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cells from genesis to pathogenesis. Cell 74: 1089-1100.
14. Slattery, R.M., J.F.A.P. Miller, W.R. Heath, and B. Charlton. 1993. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 90: 10808-10810.
15. d transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc. Natl. Acad. Sci. USA. 90: 9566-9570.
16. Boitard, C., R. Yasunami, M. Dardenne, and J.-F. Bach. 1989. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp Med. 169: 1669-1680.
17. Reich, E.-P., D. Scaringe, J. Yagi, R.S. Sherwin, and C.A. Janeway. 1989. Prevention of diabetes in NOD mice by injection of autoreactive T cells. Diabetes. 38: 1647-1651.
18. + T cell clone, I.S. 2.15 has in-vitro immunosuppressive properties. Eur. J. Immunol. 22: 2017-2023.
19. + T cell line. Diabetologia. 36: 716-721.
20. Utsugi, T., M. Nagata, T. Kawamura, and J.-W. Yoon. 1994. Prevention of recurrent diabetes in syngeneic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes. Transplantation (Balt.). 57: 1799-1804.
21. Oi, V.T., P.P. Jones, J.W. Goding, L.A. Herzenberg, and L.A. Herzenberg. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2 and la antigens. Curr. Top. Microbiol. Immunol. 81: 115-120.
22. Kappler, J.W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2 restricted, interleukin 2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp Med. 153: 1198-1214.
23. Ohara, J., and W.E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell simulatory factor-1. Nature (Land.). 315: 333-336.
24. Necker, A., N. Rebai, M. Matthes, E. Jouvin-Marche, P.-A. Cazenave, P. Swamworawong, E. Palmer, H.R. MacDonald, and B. Malissen. 1991. Monoclonal antibodies raised against engineered soluble mouse T cell receptors and specific for Vα8-, Vβ2- or Vβl0-bearing T cells. Eur. J. Immunol. 21: 3035-3040.
25. Staerz, U.D., H.-G. Rammensee, J.D. Benedetto, and M.J. Bevan. 1985. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J. Immunol. 134: 3994-4000.
26. + T cells. J. Exp Med. 170: 135-143.
27. Hurtenbach, U., E. Lier, L. Adrioni, and Z.A. Nagy. 1993. Prevention of autoimmune diabetes in nonobese diabetic mice by treatment with a class II major histocompatibility complex blocking peptide. J. Exp Med. 177: 1499-1504.
28. Brunstedt, J., J.H. Nielsen, and A. Lemmark. 1985. Isolation of islets from mice and rats. In Methods in Diabetes Research. J. Larner and S.L. Pohl, editors. John Wiley & Sons, Inc., New York. 1: 245-265.
29. Baker, P.E., S. Gillis, and K.A. Smith. 1979. Monoclonal cytolytic T cell lines. J. Exp Med. 149: 273-278.
30. Lipes, M.A., A. Rozenzweig, K.-N. Tan, G. Tanigawa, D. Ladd, J.G. Seidman, and G.S. Eisenbarth. 1993. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. Science (Wash. DC). 259: 1165-1169.
31. Karjalainen, J., J.M. Martin, M. Knip, J. Ilonen, B.H. Robinson, E. Savilahti, H.K. Akerblom, and H.M. Dosh. 1992. A bovine serum albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N. Engl. J. Med. 327: 302-307.
32. Mosmann, T.R., and R.L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
33. Malissen, M., C. McCoy, D. Blanc, J. Trucy, C. Devaux, A.-M. Schitt-Verhulst, F. Fitch, L. Hood, and B. Malissen. 1986. Direct evidence for chromosomal inversion during T-cell receptor beta-gene rearrangements. Nature (Lond.). 319: 28-32.
34. Chou, H.S., S.J. Anderson, M.C. Louie, S.A. Godambe, M.R. Pozzi, M.A. Behlke, K. Huppi, and D.Y. Loh. 1987. Tandem linkage and unusual RNA splicing of the T-cell receptor beta-chain variable-region genes. Proc. Natl. Acad. Sci. USA. 84: 1992-1996.
35. Barth, R.K., B.S. Kim, N.C. Lan, T. Hunkapiller, N. Sobieck, A. Winoto, H. Gershenfeld, C. Okada, D. Hansburg, I.L. Weissman, and L. Hood. 1985. The murine T cell receptor employs a limited repertoire of expressed Vβ gene segments. Nature (Lond.). 316: 517-523.
36. Gascoigne, N.R., Y.-H. Chien, D.M. Becker, J. Kavaler, and M.M. Davis. 1984. Genomic organization and sequence of T cell receptor beta-chain constant- and joining-region genes. Nature (Lond.). 310: 387-391.
37. Wicker, L.S., B.J. Miller, and Y. Mullen. 1986. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 35: 855-860.
38. Lantz, M., H. Thysell, E. Nisson, and I. Olson. 1991. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J. Clin. Invest. 88: 2026-2031.
39. Lortat-Jacob, H., and J.-A. Grimaud. 1991. Interferon gamma c-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate the activity. Cell. Mol. Biol. (Oxf.). 37: 253-260.
40. McCaffrey, T.A., D.J. Falcone, and B. Du. 1992. Transforming growth factor j3-l is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGFβ-1. J. Cell. Physiol. 152: 430-440.
41. Weksler, M.E., C.E. Moody, and R.W. Kozak. 1981. The autologous mixed lymphocyte reaction. Adv. Immunol. 31: 271-312.
42. Glimcher, L.H., A.D. Steinberg, S.B. House, and I. Green. 1980. The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease. J. Immunol. 125: 1832-1888.
43. Serreze, D.V., and E.H. Leiter. 1988. Defective activation of T suppresor cell function in nonobese diabetic mice. J. Immunol. 140: 3801-3807.
44. Baxter, A.G., M.A. Adams, and T.E. Mandel. 1989. Comparision of high-and-low diabetes incidence NOD mouse strains. Diabetes. 38: 1296-1300.
45. Clayberger, C., R.H. Dekruyff, and H. Cantor. 1984. Immunoregulatory activities of autoreactive T cells: an I-A-specific T cell clone mediates both help and suppression of antibody responses. J. Immunol. 132: 2237-2243.
46. Jorgensen, J.L., U. Esser, B.F. De St. Groth, P.A. Reay, and M.M. Davis. 1992. Mapping T-cell receptor-peptide contacts by variant immunization of single-chain transgenics. Nature (Lond.). 355: 244-230.
47. Jacob, C.O., S. Aiso, S.A. Michie, H.O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl. Acad. Sci. USA. 87: 968-972.
48. Yang, X.D., R. Tisch, S.M. Singer, Z.A. Cao, R.S. Liblau, R.D. Schreiber, and H.O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp Med. 180: 995-1004.
49. Campbell, I.L., L. Oxbrow, and L.C. Harrison. 1991. Reduction in insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse. J. Autoimmun. 4: 249-262.
50. Debray-Sachs, M., C. Carnaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa, and J.F. Bach. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun. 4: 237-248.
51. Mason, D., and D. Fowell. 1992. T-cell subsets and autoimmunity. Curr. Opin. Immunol. 4: 728-732.
52. Scott, B., R. Liblau, S. Degermann, L.A. Marconi, L. Ogata, A. J. Caton, H.O. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1: 73-82.
53. Wogensen, L., M.-S. Lee, and N. Sarvetnick. 1994, Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp Med. 179: 1379-1384.
54. Anderson, J.T., A.J. Cornelius, A.J. Jarpe, W.E. Winter, and A.B. Peck. 1993. Insulin-dependent diabetes in NOD mouse model II. β cell destruction in autoimmune diabetes is a Th2 and not Th1 mediated event. J. Autoimmun. 15: 113-122.